Swiss Itch Registry
Conditions: Chronic Pruritus (CP) Interventions: Other: Data collection Sponsors: University Hospital, Basel, Switzerland Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 7, 2023 Category: Research Source Type: clinical trials
Nearly 80% of Patients with Moderate-to-Severe Atopic Dermatitis Maintained Clear or Almost Clear Skin with Lilly's Lebrikizumab Monthly Maintenance Dosing at Two Years
INDIANAPOLIS, Oct. 20, 2023 /PRNewswire/ -- Patients with moderate-to-severe atopic dermatitis who continued treatment with investigational lebrikizumab for up to two years experienced sustained skin clearance, itch relief and reduced disease... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - October 20, 2023 Category: Pharmaceuticals Source Type: clinical trials
Investigation of the Effects of Sleep Deprivation on Itch and Pain Sensitivity
Conditions: Histamine; Cowhage; Sleep Deprivation Interventions: Other: Histamine; Other: Cowhage Sponsors: Aalborg University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 13, 2023 Category: Research Source Type: clinical trials
Investigation of the Effects of Sleep Fragmentation on Itch and Pain Sensitivity
Conditions: Histamine; Cowhage; Sleep Fragmentation Interventions: Other: Histamine; Other: Cowhage Sponsors: Aalborg University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 13, 2023 Category: Research Source Type: clinical trials
Characterization of Bovine Adrenal Medulla as a Model of Non-histaminergic Itch
Condition: Itch Interventions: Drug: CA and BAM8-22; Drug: Vehicle and BAM8-22 application; Drug: CA; Drug: vehicle Sponsor: Aalborg University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 14, 2023 Category: Research Source Type: clinical trials
Pharmacokinetics, Mass Balance, and Metabolism of [14C]HSK21542 in Healthy Adult Male Volunteers.
Condition: Peripheral Analgesic and Anti-itch Intervention: Drug: [14C]HSK21542 Sponsors: Haisco Pharmaceutical Group Co., Ltd.; The First Affiliated Hospital of Soochow University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 28, 2023 Category: Research Source Type: clinical trials